Akorn Again Hit With Fraud Suit Over Post-Merger Accounting
Pharmaceutical company Akorn Inc. was slammed Wednesday in Illinois federal court with another derivative suit over errors the company allegedly made integrating two major acquisitions into its accounting system, this time...To view the full article, register now.
Already a subscriber? Click here to view full article